Recombinant Pseudomonas putida UPF0745 protein PP_4590 (PP_4590)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline for your process.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a particular tag, please specify this in your order for preferential development.
Synonyms
PP_4590YcgL domain-containing protein PP_4590
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-97
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)
Target Names
PP_4590
Target Protein Sequence
MKRICSIYKSPRKNEMYLYVLKADGLERVPEGLLPFFGTPVHAFDLVLTPERKLAREDIT KVLENLESQGYHLQMPPLEDEYIEHLPEELLRRNDPV
Uniprot No.

Q&A

What is Pseudomonas putida and why is it significant as a research model?

Pseudomonas putida is a non-pathogenic soil bacterium that has become an important chassis for metabolic engineering and synthetic biology applications. It serves as a versatile "synthetic biology chassis and metabolic engineering platform" valued for its ability to be engineered to metabolize various carbon sources, including those it doesn't naturally consume, such as D-xylose. P. putida is particularly significant for protein studies due to its robust genetic malleability, metabolic versatility, and capacity to express recombinant proteins effectively.

What standard growth conditions are recommended for P. putida cultivation when studying recombinant proteins?

When cultivating P. putida for protein studies, typical conditions include:

ParameterStandard ValueOptimization Notes
MediaM9 minimal mediumSupplemented with appropriate carbon source
Carbon source0.2% (w/v) preferred substrateD-xylose used in engineered strains
Antibiotic60 μg ml−1 streptomycinFor selection of recombinant strains
Temperature30°COptimal for P. putida growth
AerationHighEssential for aerobic metabolism
Culture volume20 ml (laboratory scale)For routine protein expression
Cell densityOD600 [0.1-0.5]Maintained through dilution

These conditions provide optimal growth while maintaining selection pressure for recombinant strains carrying proteins of interest like PP_4590.

What are the main challenges in expressing recombinant proteins in P. putida compared to E. coli?

While P. putida offers advantages as a host organism, researchers face several challenges when expressing recombinant proteins that differ from traditional E. coli systems:

  • Codon optimization requirements specific to P. putida

  • Different promoter strength and regulation mechanisms

  • Need for specialized vectors with appropriate origin of replication

  • Potential biofilm formation during extended cultivation periods

  • Differences in protein folding machinery and post-translational modifications

  • More complex genetic manipulation techniques required

These challenges necessitate adapted protocols when working with recombinant proteins like PP_4590 in P. putida.

What genetic modification strategies are most effective for recombinant protein expression in P. putida?

Based on current research, effective genetic modification strategies for P. putida include:

  • Transposon-based integration using mini-Tn7 delivery vectors (e.g., pSK02)

  • Site-specific integration at the attTn7 locus for stable expression

  • Four-parental mating procedures involving:

    • Recipient P. putida strain

    • Helper strain (E. coli HB101 pRK2013)

    • Transposase-leading strain (E. coli DH5αλpir pTNS1)

    • Donor strain carrying the gene of interest

  • Gibson Assembly for vector construction

  • CRISPR-Cas9 systems adapted for Pseudomonas

For proteins like PP_4590, chromosomal integration via mini-Tn7 vectors offers stable, long-term expression without antibiotic selection pressure once established.

How can vectors be designed specifically for optimal expression of the PP_4590 protein?

When designing vectors for PP_4590 expression in P. putida, consider the following:

Vector ComponentRecommendationRationale
BackboneMini-Tn7 based (e.g., pSK02) Enables stable chromosomal integration
PromoterNative P. putida promoter or well-characterized synthetic promoterBetter recognized by P. putida transcription machinery
RBSOptimized for P. putidaEnsures efficient translation initiation
Selection markerAntibiotic resistance (e.g., streptomycin)For initial selection of transformants
Origin of replicationCompatible with P. putidaIf plasmid-based expression is desired
Fusion tagsC-terminal His-tag or FLAG-tagFor protein purification and detection

Vector construction can be performed using Gibson Assembly methods as demonstrated for pKS03 vector generation in similar P. putida studies .

What screening methods are most effective for identifying successful PP_4590 expression in transformed P. putida?

Effective screening approaches for recombinant protein expression include:

  • Specialized agar plates for phenotypic screening (similar to "cetrimide-blood agar plates" used for rhamnolipid producers)

  • Colony PCR to verify genetic integration

  • Western blotting using antibodies against fusion tags or the protein itself

  • Activity-based assays if the protein has a measurable function

  • Fluorescence-based screening if using reporter gene fusions

  • Mass spectrometry for protein identification and characterization

For PP_4590, developing a functional screening assay based on the protein's activity would provide the most direct verification of successful expression.

How can adaptive laboratory evolution (ALE) be applied to optimize PP_4590 protein expression in P. putida?

Adaptive laboratory evolution can significantly enhance recombinant protein expression through systematic selection for improved host strains. An effective ALE approach includes:

  • Setup of a dual-chamber semi-continuous log-phase bioreactor with anti-biofilm features

  • Recurrent incubation and dilution cycles over extended periods (42-45 days)

  • Selection pressure for improved protein expression (e.g., linking expression to growth advantage)

  • Genome sequencing of evolved strains to identify beneficial mutations

What purification strategies are most effective for isolating recombinant PP_4590 protein from P. putida?

Although specific purification protocols for PP_4590 weren't described in the search results, effective strategies for recombinant proteins from P. putida generally include:

  • Affinity chromatography using fusion tags (His-tag, FLAG-tag)

  • Ion exchange chromatography based on protein properties

  • Size exclusion chromatography for final polishing

  • Specialized extraction buffers optimized for P. putida proteins

  • Cell lysis optimization to account for differences in P. putida cell wall properties

For membrane-associated or surface-displayed proteins, foam fractionation methods may also be applicable, as referenced in genetic cell-surface modification studies .

How do mutations in RNA polymerase affect recombinant protein expression in P. putida?

Research has identified that RNA polymerase mutations can significantly impact protein expression and cellular fitness in P. putida. Key findings include:

GeneMutationEffect on ExpressionMechanism
rpoCPro51LeuEnhanced growth rateGlobal transcriptional changes
rpoCVarious mutationsIncreased protein productionModified transcription efficiency

The rpoC gene of evolved P. putida strains has shown point mutations (C → T in codon 51) causing a Pro51Leu change in the β' subunit of RNA polymerase. This mutation notably increased cellular fitness and growth rate, particularly when expressing non-native pathways . Similar rpoC mutations have been reported in E. coli evolution studies aimed at increasing growth rate, suggesting a conserved mechanism for adaptation across bacterial species.

These mutations likely alter global gene expression patterns, potentially enhancing recombinant protein production efficiency. For PP_4590 expression, engineering strains with optimized RNA polymerase could provide significant advantages.

How can biofilm formation be prevented during long-term cultivation of P. putida expressing recombinant PP_4590?

Biofilm formation presents a significant challenge in P. putida research, particularly during extended cultivation periods. Effective prevention strategies include:

  • Implementation of specialized anti-biofilm reactor designs as described in ALE experiments

  • Optimization of media composition to discourage biofilm formation

  • Controlled agitation and flow rates to prevent cell attachment

  • Periodic cleaning protocols integrated into automated systems

  • Surface modifications of cultivation vessels

  • Genetic modifications to reduce biofilm-forming capacity if the pathway doesn't interfere with PP_4590 expression

The successful implementation of these approaches has enabled continuous cultivation of P. putida for periods exceeding 45 days in ALE experiments .

What strategies can address protein misfolding or inclusion body formation when expressing PP_4590 in P. putida?

Protein misfolding challenges can be addressed through:

  • Optimization of expression conditions:

    • Lower induction temperature (20-25°C)

    • Reduced expression rate using weaker promoters

    • Co-expression of molecular chaperones

  • Protein engineering approaches:

    • Domain-based expression

    • Fusion with solubility-enhancing partners

    • Codon optimization for P. putida

  • Process modifications:

    • Periplasmic expression to facilitate disulfide bond formation

    • Secretion to the extracellular medium

    • Surface display using appropriate anchor proteins

These approaches have proven successful for challenging proteins in P. putida and would likely be applicable to PP_4590 expression optimization.

What statistical approaches are recommended for analyzing protein expression variability across different P. putida strains?

For robust analysis of protein expression data across different P. putida strains, consider:

  • ANOVA with post-hoc tests for comparing multiple strains

  • Mixed-effects models to account for batch variations

  • Principal component analysis for multivariate data exploration

  • Non-parametric methods if data doesn't meet normality assumptions

  • Time-series analysis for expression dynamics

  • Hierarchical clustering to identify patterns across different experimental conditions

When comparing evolved strains, it's crucial to account for both genetic differences and experimental variability to accurately attribute expression changes to specific mutations.

How should experiments be designed to evaluate the impact of PP_4590 expression on P. putida fitness?

A comprehensive experimental design to evaluate fitness impacts would include:

  • Growth curve analysis comparing wild-type and recombinant strains

  • Competition assays between expressing and non-expressing strains

  • Metabolic flux analysis to identify perturbations

  • Transcriptomic and proteomic profiling to detect stress responses

  • Adaptive laboratory evolution with and without expression

  • Fitness measurements under various environmental stresses

These approaches would provide a holistic understanding of how PP_4590 expression affects cellular physiology, potentially identifying unexpected interactions with native cellular processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.